InnovAge
INNV
#5367
Rank
NZ$2.76 B
Marketcap
NZ$20.38
Share price
2.87%
Change (1 day)
223.62%
Change (1 year)

Earnings for InnovAge (INNV)

Earnings in 2026 (TTM): -NZ$23.46 Million

According to InnovAge's latest financial reports the company's current earnings are NZ$0.94 Billion. In 2025 the company made an earning of NZ$8.81 Million, an increase over its 2024 earnings that were of -NZ$45.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for InnovAge from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$23.46 Million-366.05%
2025 NZ$8.81 M-119.56%
2024 -NZ$45.08 Million-24.58%
2023 -NZ$59.76 Million-31.82%
2022 -NZ$87.66 Million-681.94%
2021 NZ$15.06 M-388.91%
2020 -NZ$5.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
NZ$22.69 B-96,784.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Cocrystal Pharma
COCP
-NZ$15.59 Million-33.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-NZ$17.76 Million-24.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
NZ$0.88 B-3,867.87%๐Ÿ‡ฎ๐Ÿ‡ช Ireland